Press Releases

 Filter by Provider

ECS, a provider of advanced technology solutions in data and AI, cybersecurity, and enterprise transformation, and an ASGN (NYSE: ASGN Incorporated) brand, received the 2025 Elastic Services Partner Award – AMER from Elastic, the Search AI company. The award was presented to ECS at ElasticON ENGAGE NYC on October 8, 2025.

In a market saturated with commodity beans and flavor-chasing trends, Christ Coffee stands apart. The company’s foundation is built on the belief that luxury isn’t just what you wear, or where you go—it’s what you stand behind. By sourcing beans ethically, roasting with precision, and packaging each bag with purpose, Christ Coffee delivers a cup that tastes exceptional and carries a story.

Aclipse Therapeutics LLC (“Aclipse” or “the Company”) today announced that it has entered into a clinical collaboration and Know-How Agreement with Mayo Clinic for the Phase 2 clinical development of M107, the Company’s novel small molecule drug candidate being advanced as a potential disease modifying treatment for gastroparesis (i.e., stomach paralysis). The collaboration leverages the combined scientific and clinical expertise of both organizations to target macrophage related inflammation and seeks to address the biological cause of gastroparesis, a chronic and debilitating disease affecting stomach nerves and muscles resulting in stomach paralysis and delayed stomach emptying.

Get Rewards, Manage Memberships and More Exclusive Perks

Landmarks Nationwide Shine Green November 18 for National Injury Prevention Day

The up to $1.4M collaboration will enable manufacturing “universal” islets containing a drug-inducible safety feature designed to make curative therapies accessible without the need for chronic immunosuppression

SAN DIEGO, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with inflammation-mediated cardiovascular and neurodegenerative diseases, today announced that Company executives will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference in London.

Maranello (Italy), November 17, 2025 – Ferrari N.V. (NYSE/EXM: RACE) (“Ferrari” or the “Company”) informs that the Company has purchased, under the Euro 360 million share buyback program announced on July 31, 2025, as the eighth tranche of the multi-year share buyback program of approximately Euro 2 billion expected to be executed by 2026 in line with the disclosure made during the 2022 Capital Markets Day (the “Eighth Tranche”), the additional common shares - reported in aggregate form, on a daily basis - on the Euronext Milan (EXM) and on the New York Stock Exchange (NYSE) as follows:

US NEWS – The cryptocurrency mining market is growing steadily: according to recent market analysis, the global industry size will reach approximately $14.81 billion in 2025 (2024: $14.4 billion). New, legally compliant digital wealth channels are transforming the US pension system. In the US, a growing number of retirees are quietly exploring a new frontier: the […]

Mordor Intelligence has published a new report on the Urea Market, offering a comprehensive analysis of trends, growth drivers, and future projections.

Regional geochemical soil sampling highlights a large and untested copper anomaly parallel to the Storm trend

VANCOUVER, BC / ACCESS Newswire / November 17, 2025 / Earthwise Minerals Corp. (CSE:WISE)(FSE:966) ("Earthwise" or the "Company") is pleased to announce that it has received results from 2025 fieldwork with samples grading up to 13.4 g/t Au, 27.2 g/t Ag, > 10,000 ppm As, and 2.7% Pb. Earthwise holds the exclusive option to acquire up to an 80% interest in the Iron Range Project from Eagle Plains Resources Ltd. (TSX-V:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains").

Optimizes Capital Structure and Financial Flexibility

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in patients with Cancer.

ROSHARON, TX / ACCESS Newswire / November 17, 2025 / The world is bracing for the inevitable impact of quantum computing on cybersecurity and Signal Advance Inc. (OTC:SIGL) has taken a pivotal step forward with its Analog Guard® technology - a physics-based encryption platform developed to outpace quantum threats.

CRANBROOK, BC / ACCESS Newswire / November 17, 2025 / Eagle Plains Resources Ltd. (TSXV:EPL)(OTCQB:EGPLF) ("EPL" or "Eagle Plains") is pleased to announce that partner Earthwise Minerals Corp. (CSE:WISE) ("Earthwise" or "WISE") has received results from 2025 fieldwork at Eagle Plains 100% owned Iron Range Project. Earthwise holds the exclusive option to acquire up to an 80% interest in the Iron Range Project.

Spin-Out from the Women Founders of InHealth Launches Seed Round to Scale Modular, Evidence-Based AI Coaching Platform

Kimbo, a Neapolitan heritage of high‑quality coffee actually available in 100 countries worldwide, once again captivated the audience at Host Milano 2025, the global hospitality hub, with its brand new and longstanding coffee lines, a full range of business solutions for the "out-of-home" settings - from professional whole‑bean coffees to single‑serving formats.

Toronto, Ontario--(Newsfile Corp. - November 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a...

A new report from Modern Health, a leading global workplace mental health platform, reveals that while full-time, Return-to-Office (RTO) mandates remain one of the most polarizing issues, they also represent one of the most promising opportunities for companies to reexamine their workplace culture and the level of support and resources they’re providing to their employees.

GE HealthCare (Nasdaq: GEHC) today announced that Cardiovascular Associates of America (CVAUSA), the largest network of private cardiology groups in the U.S., plans to broaden its adoption of GE HealthCare’s FDA-approved cardiac positron emission tomography (PET) radiotracer Flyrcado™ (flurpiridaz F 18) injection, across approximately 25 sites following a successful pilot at Cardiovascular Medicine in Davenport, Iowa. This planned rollout marks a significant milestone for advancing PET myocardial perfusion imaging (MPI) in community cardiology settings and reflects growing confidence in Flyrcado’s role in shaping the future of cardiac imaging.

OSI Systems, Inc. (NASDAQ: OSIS) (the “Company” or “OSI”) today announced its intention to offer, subject to market and other conditions, $400 million aggregate principal amount of convertible senior notes due 2031 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). OSI also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 days from, and including, the date the notes are first issued, up to an additional $60.0 million principal amount of notes.

Hyliion Holdings Corp. (NYSE American: HYLN) (“Hyliion”), a developer of modular power plant technology, today announced the successful demonstration of dynamic fuel switching in its KARNO Power Module. The system transitioned between natural gas and propane while under load, maintaining continuous power generation without interruption, shutdown, or hardware changes. This demonstration showcases the KARNO system’s ability to adapt to new fuel sources in real time while still maintaining power output, advancing the future of resilient and sustainable power generation.

The booming satellite industry just received a massive cost-saving injection paired with unprecedented ease of integration. VORAGO Technologies today announced a world first: the launch of four radiation-tolerant microcontrollers purpose-built for low Earth orbit (LEO) markets at a fraction of the cost of traditional space-grade components, with first chips shipping in early Q1 2026.

Palladyne AI Corp. (NASDAQ: PDYN and PDYNW) (“Palladyne” or “the Company”), a developer of artificial intelligence software for autonomous platforms in the defense and commercial sectors, today announced the acquisitions of GuideTech LLC. (“GuideTech”), and two Crucis companies: Warnke Precision Machining and MKR Fabricators (the “Crucis Companies”). The acquisitions, combined with the defense variant of Palladyne™ Pilot embodied AI for drones, now branded as SwarmOS™, create Palladyne Defense, a new operating division of Palladyne AI that unites patented embodied AI, UAV and loitering munitions components and systems, advanced engineering and U.S.-based manufacturing. Palladyne Defense will immediately deliver revenue-generating programs and scalable U.S. production capacity while advancing the Department of War’s modernization priorities, including intelligent autonomy, rapid iteration, low cost per effect and the reshoring of critical defense production.

Andor Health:

MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced that C.D. Baer Pettit, President and Chief Operating Officer (COO), and a member of the Board of Directors, has informed the company that he will retire next year after more than 25 years in senior leadership roles. Mr. Pettit will continue to serve as President and a Director until March 1, 2026, and will remain as an advisor to the company for a period of time to ensure a smooth transition.

Augurex Life Sciences Corp., a leader in the development of autoimmune-based diagnostics, today announced the upcoming launch of the 14-3-3eta test, approved as JOINTstat® in Canada and the UK, through Sonic Reference Laboratory, a division of Sonic Healthcare USA. Beginning December 15, 2025, the test will be available to healthcare providers across the United States as part of Sonic’s diagnostic portfolio. The 14-3-3eta test improves early detection and management of rheumatoid arthritis (RA), providing clinicians with a powerful tool to enhance care and optimize outcomes.

Gibraltar Industries, Inc. (Nasdaq: ROCK), a leading manufacturer and provider of products and services for the residential, agtech, and infrastructure markets, today announced that it has reached an agreement to acquire OmniMax International (“OmniMax”) from funds managed by Strategic Value Partners, LLC and its affiliates (together “SVP”) for a cash purchase price of $1.335 billion. OmniMax is a leader in residential roofing accessories and rainware solutions with expected 2025 adjusted net sales of $565 million and adjusted EBITDA of $110 million. The purchase price represents an effective multiple of 8.4x based on OmniMax’s expected 2025 adjusted EBITDA, run rate cost synergies of $35 million, and cash tax benefits of approximately $100 million.

AdvanCell Pty Ltd (“AdvanCell”), a clinical-stage radiopharmaceutical company developing innovative targeted alpha therapies for cancer, today announced the appointment of Philina Lee, PhD as Chief Executive Officer and member of the Board of Directors. Dr Lee will head AdvanCell’s US expansion, accelerating clinical, manufacturing, and partnership activities to advance lead clinical candidate 212Pb-ADVC001 and the company’s innovative radiopharmaceutical portfolio. She will assume her role from January 1, 2026, and will be based at the company’s new US headquarters near Boston/Cambridge, MA.

Accelsius, the leader in two-phase, direct-to-chip liquid cooling for AI and high-performance computing, today announced that DarkNX, a global digital infrastructure company, has entered into an agreement to deploy Accelsius’ NeuCool® technology across a new 300MW AI data center campus in Ontario, Canada. The project is expected to be the largest two-phase, direct-to-chip deployment to date, signaling a major shift toward large-scale industry adoption of next-generation cooling.

Lili, the leading financial platform that offers business banking, credit building, and accounting solutions for small and mid-sized businesses, today announced an increase in FDIC insurance coverage to $3M through partner bank Sunrise Banks, N.A., and a new tiered high-yield savings structure offering up to 4.00% Annual Percentage Yield (APY)¹, which is up from 2.5%. Business savings balances over $500,000 now earn 4.00% APY, while balances under $500,000 continue to earn 2.50% APY– more than 9x higher the national average.

ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the initiation of Part 3 of its ongoing Phase 2 clinical trial evaluating RCT2100, an investigational inhaled CFTR mRNA therapy, in combination with ivacaftor in people with cystic fibrosis (CF). Clinical sites in the United States are now open for enrollment. The company plans to begin enrolling participants at sites in the United Kingdom and the European Union in the first quarter of 2026. For more information, please visit CF-Clinical-Studies.com.

Camunda, the leader in agentic automation, has announced new ServiceNow integrations that enable enterprises to further orchestrate long-running, end-to-end processes across different systems, people, automation tools, and AI agents. Organizations can model and execute processes in Camunda using Business Process Model and Notation (BPMN) and Decision Model and Notation (DMN) standards, while keeping ServiceNow as the system of record. This approach improves visibility, flexibility, and integration across heterogeneous IT environments.

The five defining trends set to reshape cocktail culture and the spirits industry in 2026 are highlighted in the seventh annual Bacardi Cocktail Trends Report. The Report released by Bacardi Limited, the largest privately held international spirits company, in partnership with The Future Laboratory (TFL), draws on data from Bacardi-led and third-party research, consumer surveys, bartender interviews and TFL’s trend forecasting to uncover the forces shaping cocktail experiences, flavor innovation, and drinking culture in the year ahead. The Report also reveals the cocktails which are set to be the most popular in 2026 and trends for younger Legal Drinking Age (LDA) consumers.

Houston, Texas and Tuebingen, Germany, November 17, 2025 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), a clinical-stage biopharmaceutical company and the global leader in precision targeting of PRAME, today provided a business update and reported financial results for the quarter ended September 30, 2025.

Collaboration aims to create scalable digital health solutions that enable safe, connected, and independent living for aging adults

UK government-backed production facilities, expected to be operational in 2027, will be the largest electrolyzer installation in the country and will supply green hydrogen to decarbonize local industrial operations

Net Revenues Increased by 50.2% Year-over-Year to RMB15.3 Billion

DURHAM, N.C., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced the appointment of Agnieszka (Aggie) M. Gallagher as general counsel. Gallagher is responsible for the Company’s legal strategy and operations, serving as corporate secretary, chief compliance officer and as a member of Fortrea’s leadership team. She succeeds J. Stillman Hanson, who is leaving the Company after a planned transition period.

Dealers face a 16:1 visibility gap against independent repair shops

Castle also earns national recognition through three additional Top Workplaces Culture Excellence Awards — Employee Appreciation, Employee Well-Being and Professional Development

CARLSBAD, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Aptera Motors Corp. (NASDAQ: SEV) ("Aptera" or the "Company"), a solar mobility company pioneering ultra-efficient transportation, today reported its financial results for the third quarter ended September 30, 2025.

Hong Kong, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Cre8 Enterprise Limited (Nasdaq: CRE) (“Cre8” or the “Company”), a Hong Kong-based integrated financial printing service provider, announced today the launch of a new digital payment initiative that enables clients to settle payments using crypto-currencies, including USD Coin (USDC), Tether (USDT), and Bitcoin (BTC).

NEW YORK, Nov. 17, 2025 (GLOBE NEWSWIRE) -- The Vita Coco Company, Inc. (NASDAQ: COCO) (“Vita Coco” or the “Company”), a leading high-growth platform of better-for-you beverage brands, today provided the following response to the recent Executive Order modifying the scope of the reciprocal tariff with respect to certain agricultural products.

IRVINE, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Mobix Labs, Inc. (NASDAQ: MOBX) (“Mobix”), a fast-growing semiconductor and defense-technology company, announced today that it has filed a Verified Complaint in the Delaware Court of Chancery alleging that Tik Yang Tse (also known as Denis Tse), ACE Equity Partners International, Asia-IO Equity Partners International, and ACE SO4 Holdings Limited engaged in fraudulent conduct, intentional misrepresentations, and a breach of contract governing ACE’s binding investment obligations.

Palantir (NASDAQ: PLTR), a leading provider of AI software, and FTAI Aviation Ltd. (NASDAQ: FTAI), a global leader in aircraft engine maintenance, today announced a multi-year strategic partnership, which will allow FTAI to leverage Palantir’s Artificial Intelligence Platform (“AIP”) across FTAI’s global maintenance footprint.

NielsenIQ (NYSE: NIQ), a leading consumer intelligence company, and Essity, a global leader in hygiene and health, today announced that Essity has selected NIQ as its primary provider for point-of-sale and consumer intelligence solutions across the U.S., becoming Essity’s main North American data and insights supplier. This move aligns Essity’s U.S. business with its global organization, establishing a unified, holistic relationship with NIQ across all regions. Together, Essity and NIQ will deliver a consistent, world-class approach to data, analytics, technology, and innovation.

Arada, the UAE’s fastest-growing master developer, announces that it has agreed the acquisition of an 80% stake in Thameside West, a landmark waterfront mixed-use development located at the western end of London’s Royal Docks.

HOUSTON, TX / ACCESS Newswire / November 17, 2025 / PEDEVCO Corp. (NYSE American:PED) ("PEDEVCO" or the "Company"), an energy company engaged in the acquisition and development of strategic, high growth energy projects in the United States, with a focus on the Rocky Mountain region, announced its financial results for the three months ended September 30, 2025 and provided an operations update, which financial results do not reflect the effect of the Company's October 31, 2025 transformative merger with certain portfolio companies controlled by Juniper Capital Advisors, L.P., as announced by the Company on November 3, 2025.